Covered recipient · General Payments record
IMAN DOOSTAN
Allopathic & Osteopathic Physicians Internal Medicine Hematology & Oncology
General Payments · PY2019–2024
$2,258.38
- Reported across 32 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $426.01 | 12 |
| Education | $298.94 | 3 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| SEAGEN INC. | $199.94 | 2 |
| Incyte Corporation | $147.56 | 3 |
| AVEO Pharmaceuticals, Inc. | $123.67 | 1 |
| Takeda Pharmaceuticals U.S.A., Inc. | $58.91 | 2 |
| JAZZ PHARMACEUTICALS INC. | $55.40 | 2 |
| EISAI INC. | $33.18 | 1 |
| BeiGene USA, Inc. | $30.11 | 1 |
| PFIZER INC. | $27.16 | 1 |
| ABBVIE INC. | $25.21 | 1 |
| Lilly USA, LLC | $23.81 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (15)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $25.21 | 02/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103653672 | CMS |
| Aveo Pharmaceuticals, Inc. | $123.67 | 06/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143478793 | CMS |
| BeiGene USA, Inc. | $30.11 | 09/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120851928 | CMS |
| Eisai Inc. | $33.18 | 11/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110749580 | CMS |
| Incyte Corporation | $20.24 | 01/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141184498 | CMS |
| Incyte Corporation | $99.00 | 03/25/2024 | Education | Undisputed | 01/23/2026 | 1141320277 | CMS |
| Incyte Corporation | $28.32 | 10/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141298721 | CMS |
| JAZZ PHARMACEUTICALS INC. | $29.71 | 05/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150218479 | CMS |
| JAZZ PHARMACEUTICALS INC. | $25.69 | 11/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150218481 | CMS |
| Lilly USA, LLC | $23.81 | 08/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135026648 | CMS |
| PFIZER INC. | $27.16 | 11/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131565974 | CMS |
| SEAGEN INC. | $99.95 | 09/18/2024 | Education | Undisputed | 01/23/2026 | 1131908074 | CMS |
| SEAGEN INC. | $99.99 | 09/18/2024 | Education | Undisputed | 01/23/2026 | 1131908267 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $29.09 | 01/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144956715 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $29.82 | 02/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137533316 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2019, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.